DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 77 filers reported holding DYNE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,303 | -20.4% | 815,085 | 0.0% | 0.31% | +10.2% |
| Q2 2023 | $9,170 | +49.4% | 815,085 | +53.0% | 0.28% | -22.2% |
| Q1 2023 | $6,136 | +0.8% | 532,609 | +1.4% | 0.36% | +7.4% |
| Q4 2022 | $6,085 | -99.9% | 525,000 | 0.0% | 0.34% | +19.3% |
| Q3 2022 | $6,668,000 | +84.9% | 525,000 | 0.0% | 0.28% | +47.7% |
| Q2 2022 | $3,607,000 | -28.7% | 525,000 | 0.0% | 0.19% | -9.0% |
| Q1 2022 | $5,061,000 | -18.9% | 525,000 | 0.0% | 0.21% | +25.4% |
| Q4 2021 | $6,242,000 | -26.8% | 525,000 | 0.0% | 0.17% | -11.5% |
| Q3 2021 | $8,526,000 | -22.8% | 525,000 | 0.0% | 0.19% | -14.7% |
| Q2 2021 | $11,046,000 | +35.5% | 525,000 | 0.0% | 0.22% | +55.6% |
| Q1 2021 | $8,153,000 | +29.4% | 525,000 | +75.0% | 0.14% | +6.7% |
| Q4 2020 | $6,300,000 | -15.7% | 300,000 | -18.9% | 0.14% | -25.4% |
| Q3 2020 | $7,470,000 | – | 370,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |